Brain Hemorrhage

3

Review clinical trials related to Brain Hemorrhage. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Prognostic Analysis of Different Treatment Options for Cerebral Hemorrhage

To analyze the influence of early hematoma morphology on hematoma expansion, optimize the treatment plan for cerebral hemorrhage, and guide the treatment of patients with cerebral hemorrhage in combination with clinical practice.

Participants needed: 1,000
Trial details
Age: 18-80Biological sex: AllType: ObservationalSponsor: The Affiliated Hospital Of Guizhou Medical UniversityUpdated: Mar 18, 2026Locations: 1
Eligibility criteria

Age 18-80 years old; [+1]

Multiple intracranial hemorrhage; [+6]

Status: Not yet recruiting

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Intracerebral Hemorrhage(CBSinICH)

The most common cause of death for Chinese patients is intracerebral hemorrhage(ICH), particularly cerebral infarction. It places a heavy burden on people, families, and society as a whole and poses considerable risks of death and disability. The disease is difficult to identify, and is frequently detected only after it progresses to the point of vascular cognitive dysfunction. The primary ischemia necrosis of brain nerve cells and the activation of inflammatory cells are their pathologic processes. According to historical Chinese medical documents, bezoar possesses properties that can help prevent seizures, treat strokes, enhance cognitive function and mental well-being, and stimulate alertness. Calculus Bovis Sativus (CBS) is the most authentic formulation of bezoar ingredients compared to other bezoar products. It has received approval from the China Food and Drug Administration for the essential treatment of comatose patients. CBS consists of three primary constituents: bilirubin, bile acids, and taurine. Scientific evidence has demonstrated that all of these components possess anti-inflammatory, antioxidant, and neuroprotective properties. The investigators' objective is to carry out an investigator-initiated clinical study to assess the efficacy of orally administered CBS in treating intracerebral hemorrhag diseases in humans.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Tongji HospitalUpdated: Oct 1, 2025Locations: 1
Eligibility criteria

The subject and/or their legal guardian(s) must have full legal capacity, fully... [+8]

Medical History and Current Health Status [+51]

Status: Recruiting

Population-based Brest Stroke Registry

The registry is the main objective exhaustive list of cases validated stroke brain on a geographical area defined to calculate an incidence.

Participants needed: 15,000
Trial details
Age: 15+Biological sex: AllType: ObservationalSponsor: University Hospital, BrestUpdated: May 26, 2023Locations: 1Duration: 10 Years
Eligibility criteria

Ischemic stroke, [+2]

Age ≤ 15 years [+4]